GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

PAHC · Dec 31, 2025

PHIBRO ANIMAL HEALTH CORP. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001104659-26-010317General Corporate

Debt relative to revenue63thOwn-history percentile · N=8

Evidence method

Level · gp.fundamentals.debt_to_revenue

166.95% · OPTIONAL · VALID

Capex intensity30thOwn-history percentile · N=10

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

2.97% · OPTIONAL · VALID

Operating cash generation50thOwn-history percentile · N=10

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

5.18% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

20.90% · CORE · NOT_ENOUGH_HISTORY

Inventory pressure100thOwn-history percentile · N=10

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

138.36% · OPTIONAL · VALID

Gross margin100thOwn-history percentile · N=10

Evidence method

Level · gp.fundamentals.gross_margin

35.48% · CORE · VALID

Operating margin90thOwn-history percentile · N=10

Evidence method

Level · gp.fundamentals.operating_margin

13.46% · CORE · VALID

SBC intensity100thOwn-history percentile · N=9

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

0.12% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History12 statesHistory building

Jun 30, 20230/7 normalizedLevel 3 Sep 30, 20230/7 normalizedLevel 3 Dec 31, 20230/7 normalizedLevel 3 Mar 31, 20240/6 normalizedLevel 3 Jun 30, 20240/9 normalizedLevel 3 Sep 30, 20240/8 normalizedLevel 3 Dec 31, 20240/8 normalizedLevel 3 Mar 31, 20250/8 normalizedLevel 3 Jun 30, 20255/8 normalizedLevel 3 Sep 30, 20256/8 normalizedLevel 3 Dec 31, 20257/8 normalizedLevel 3 Mar 31, 20267/8 normalizedLevel 3

Period transition

What moved in the state?

Balance Sheet Leverage Decreased

Previous: 172.57%
Current: 166.95%
Delta: -5.62%

Capex Intensity Decreased

Previous: 3.79%
Current: 2.97%
Delta: -0.83%

Cash Generation Increased

Previous: 2.56%
Current: 5.18%
Delta: 2.62%

Growth Decreased

Previous: 39.73%
Current: 20.90%
Delta: -18.82%

Inventory Pressure Increased

Previous: 129.65%
Current: 138.36%
Delta: 8.71%

Margin Increased

Previous: 32.92%
Current: 35.48%
Delta: 2.56%

Profitability Decreased

Previous: 14.09%
Current: 13.46%
Delta: -0.63%

Sbc Intensity Increased

Previous: 0.09%
Current: 0.12%
Delta: 0.02%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Has State · PHIBRO ANIMAL HEALTH CORP →Transitioned To · PAHC Fundamental State →Transitioned To · PAHC BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · PAHC CAPEX_INTENSITY_DECREASED →Transitioned To · PAHC CASH_GENERATION_INCREASED →Transitioned To · PAHC GROWTH_DECREASED →Transitioned To · PAHC INVENTORY_PRESSURE_INCREASED →Transitioned To · PAHC MARGIN_INCREASED →Transitioned To · PAHC PROFITABILITY_DECREASED →Transitioned To · PAHC SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.